CDKL1 IDG kinase ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with CDKL1 IDG kinase ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with CDKL1 IDG kinase ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with CDKL1 IDG kinase ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CDKL1 IDG kinase ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

ribosomal protein S6 kinase related

Gene

zinc finger protein 37B, pseudogene

Gene

ribosomal protein L32 pseudogene 3

Gene

guanylate binding protein 1 pseudogene 1

Gene

FKBP prolyl isomerase 9 pseudogene 1

Gene

SHOX homeobox

Gene

capicua transcriptional repressor pseudogene 27

Gene

cyclin B3 pseudogene 1

  • Gene

    H4 clustered histone 15


  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    ribosomal protein S6 kinase related


  • Gene

    zinc finger protein 37B, pseudogene


  • Gene

    ribosomal protein L32 pseudogene 3


  • Gene

    guanylate binding protein 1 pseudogene 1


  • Gene

    FKBP prolyl isomerase 9 pseudogene 1



  • Gene

    capicua transcriptional repressor pseudogene 27


  • Gene

    cyclin B3 pseudogene 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.